ARTICLE | Company News
Biovitrum, Cambridge Bio Ltd. deal
March 28, 2005 8:00 AM UTC
Biovitrum will acquire Cambridge Biotechnology for an undisclosed sum. Cambridge Biotechnology is developing compounds for obesity, pain and inflammation, while Biovitrum develops compounds for metabo...